Citadel Advisors »

Akari Therapeutics Plc Sponsored shares owned by Citadel Advisors

Quarter-by-quarter ownership of Akari Therapeutics Plc Sponsored (AKTX) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Akari Therapeutics Plc Sponsored

Tip: Access up to 7 years of quarterly data

All positions including Akari Therapeutics Plc Sponsored held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akari Therapeutics Plc Sponsored by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $99k 33k 2.98

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Booking Holdings Call Option (BKNG)
Spdr Gold Tr Gold Shs Call Option (GLD)

View all positions for Citadel Advisors

Top funds holding Akari Therapeutics Plc Sponsored

Omnia Family Wealth
Citadel Advisors
HPM Partners
Renaissance Technologies
Bank of America Corporation
Advisor Group Holdings
Morgan Stanley
Cornerstone Planning Group

View all funds holding Akari Therapeutics Plc Sponsored